Correlation Between Fresh Tracks and Eupraxia Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fresh Tracks and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fresh Tracks and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fresh Tracks Therapeutics and Eupraxia Pharmaceuticals, you can compare the effects of market volatilities on Fresh Tracks and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fresh Tracks with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fresh Tracks and Eupraxia Pharmaceuticals.
Diversification Opportunities for Fresh Tracks and Eupraxia Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Fresh and Eupraxia is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Fresh Tracks Therapeutics and Eupraxia Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Fresh Tracks is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fresh Tracks Therapeutics are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Fresh Tracks i.e., Fresh Tracks and Eupraxia Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fresh Tracks and Eupraxia Pharmaceuticals
Given the investment horizon of 90 days Fresh Tracks Therapeutics is expected to generate 2.7 times more return on investment than Eupraxia Pharmaceuticals. However, Fresh Tracks is 2.7 times more volatile than Eupraxia Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Eupraxia Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 59.00 in Fresh Tracks Therapeutics on August 31, 2024 and sell it today you would earn a total of 19.00 from holding Fresh Tracks Therapeutics or generate 32.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 12.8% |
| Values | Daily Returns |
Fresh Tracks Therapeutics vs. Eupraxia Pharmaceuticals
Performance |
| Timeline |
| Fresh Tracks Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Eupraxia Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Fresh Tracks and Eupraxia Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fresh Tracks and Eupraxia Pharmaceuticals
The main advantage of trading using opposite Fresh Tracks and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fresh Tracks position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.| Fresh Tracks vs. Assembly Biosciences | Fresh Tracks vs. Instil Bio | Fresh Tracks vs. Nuvation Bio | Fresh Tracks vs. Achilles Therapeutics PLC |
| Eupraxia Pharmaceuticals vs. Akeso, Inc | Eupraxia Pharmaceuticals vs. Ascletis Pharma | Eupraxia Pharmaceuticals vs. Avax Techs | Eupraxia Pharmaceuticals vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |